Global Touch Activated Phlebotomy Device Market Growth 2026-2032
The global Touch Activated Phlebotomy Device market size is predicted to grow from US$ 244 million in 2025 to US$ 581 million in 2032; it is expected to grow at a CAGR of 12.8% from 2026 to 2032.
Touch Activated Phlebotomy Device refers to a venous blood collection device engineered around touch-triggered, often one-hand activation. It typically integrates needle protection, puncture activation, blood return indication/feedback, hemostasis support, and safety lockout in a single system to reduce procedural steps while improving consistency and safety. The device can be configured for vacuum tube collection, butterfly sets/extension tubing, or dedicated connector interfaces, serving routine laboratory phlebotomy and selected bedside sampling workflows. Its core value lies in touch-activated mechanics and closed or semi-closed fluid pathways that minimize exposed needle time and blood splashes, lowering needlestick risk, improving patient comfort, and enabling more standardized, efficient, and compliant phlebotomy operations.In 2025, global Touch Activated Phlebotomy Deviceproduction reached approximately 24.9 million units and price is about 10 usd/unit.The average gross profit margin of this product is 55%.
As healthcare providers strengthen occupational exposure prevention, infection control, and procedural standardization, safety upgrades in phlebotomy have become a firm requirement. Touch-activated phlebotomy devices align with the need to reduce steps, minimize exposure, and improve consistency—especially in high-throughput settings such as emergency departments, outpatient draw stations, and centralized pre-analytical workflows. Workforce shifts and rising training costs further favor intuitive, repeatable devices that reduce dependence on individual technique. In many institutions, “safe phlebotomy” is evolving into a system-level procurement and governance theme, driving upgrades from single consumables toward integrated offerings that combine devices, compatible disposables, and service—expanding the commercial runway for suppliers with interface ecosystems and scalable delivery capabilities.
Challenges center on clinical adaptability, cost sensitivity, and compliance validation. Venous variability, insertion angle, and activation force can influence first-stick success and patient experience; the device must deliver stable performance across patient populations and departments. Any issues such as insensitive triggering, unclear blood return feedback, or connector incompatibility can increase procedure time and complaints. Phlebotomy supplies are also high-frequency and cost-sensitive, so suppliers must balance safety upgrades with tight cost control and reliable supply. In addition, products incorporating needle safety mechanisms require robust quality systems, regulatory compliance, and real-world usability validation; inadequate training or inconsistent use can blunt the intended safety benefits and undermine repurchase and adoption within the hospital.
Demand is shifting from “usable” to “controllable, traceable, and standardized.” Providers increasingly focus on the entire pre-analytical quality chain—patient identification, collection consistency, hemolysis/clotting control, sample logistics efficiency, and documentation of occupational exposure events. Therefore, touch-activated devices must not only be safe and easy to use, but also fit seamlessly into vacuum tube systems, phlebotomy carts, and specimen management workflows. Health-check centers and IVD-related service settings emphasize throughput and low error rates, favoring solutions that shorten cycle time and reduce rework. For populations with difficult venous access (pediatrics, geriatrics, oncology), the market leans toward variants with enhanced control and clear visual/functional feedback. Overall, product portfolios are evolving toward scenario-specific series and a complementary consumable ecosystem.
Key upstream inputs include medical-grade stainless-steel cannulae and bevel grinding, medical polymers for hubs/housings and activation structures, elastomers and seals for valves and leak prevention, transparent materials for observation windows, and connector components compatible with vacuum tubes or extension sets. For safety lockout and anti-rebound mechanisms, consistency of micro-springs, latches, and precision assembly determines activation feel and reliability. Because the device contacts blood directly or operates in near-blood environments, biocompatibility, sterilization compatibility, extractables/leachables control, and batch stability are critical. At scale, injection mold accuracy, automated assembly yield, and in-line inspection capabilities become decisive. Ultimately, upstream stability and quality management translate into first-stick performance, leakage risk, and safety-mechanism reliability—forming the foundation for brand trust and long-term institutional partnerships.
LP Information, Inc. (LPI) ' newest research report, the “Touch Activated Phlebotomy Device Industry Forecast” looks at past sales and reviews total world Touch Activated Phlebotomy Device sales in 2025, providing a comprehensive analysis by region and market sector of projected Touch Activated Phlebotomy Device sales for 2026 through 2032. With Touch Activated Phlebotomy Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Touch Activated Phlebotomy Device industry.
This Insight Report provides a comprehensive analysis of the global Touch Activated Phlebotomy Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Touch Activated Phlebotomy Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Touch Activated Phlebotomy Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Touch Activated Phlebotomy Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Touch Activated Phlebotomy Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Touch Activated Phlebotomy Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Touch Activated Phlebotomy Device refers to a venous blood collection device engineered around touch-triggered, often one-hand activation. It typically integrates needle protection, puncture activation, blood return indication/feedback, hemostasis support, and safety lockout in a single system to reduce procedural steps while improving consistency and safety. The device can be configured for vacuum tube collection, butterfly sets/extension tubing, or dedicated connector interfaces, serving routine laboratory phlebotomy and selected bedside sampling workflows. Its core value lies in touch-activated mechanics and closed or semi-closed fluid pathways that minimize exposed needle time and blood splashes, lowering needlestick risk, improving patient comfort, and enabling more standardized, efficient, and compliant phlebotomy operations.In 2025, global Touch Activated Phlebotomy Deviceproduction reached approximately 24.9 million units and price is about 10 usd/unit.The average gross profit margin of this product is 55%.
As healthcare providers strengthen occupational exposure prevention, infection control, and procedural standardization, safety upgrades in phlebotomy have become a firm requirement. Touch-activated phlebotomy devices align with the need to reduce steps, minimize exposure, and improve consistency—especially in high-throughput settings such as emergency departments, outpatient draw stations, and centralized pre-analytical workflows. Workforce shifts and rising training costs further favor intuitive, repeatable devices that reduce dependence on individual technique. In many institutions, “safe phlebotomy” is evolving into a system-level procurement and governance theme, driving upgrades from single consumables toward integrated offerings that combine devices, compatible disposables, and service—expanding the commercial runway for suppliers with interface ecosystems and scalable delivery capabilities.
Challenges center on clinical adaptability, cost sensitivity, and compliance validation. Venous variability, insertion angle, and activation force can influence first-stick success and patient experience; the device must deliver stable performance across patient populations and departments. Any issues such as insensitive triggering, unclear blood return feedback, or connector incompatibility can increase procedure time and complaints. Phlebotomy supplies are also high-frequency and cost-sensitive, so suppliers must balance safety upgrades with tight cost control and reliable supply. In addition, products incorporating needle safety mechanisms require robust quality systems, regulatory compliance, and real-world usability validation; inadequate training or inconsistent use can blunt the intended safety benefits and undermine repurchase and adoption within the hospital.
Demand is shifting from “usable” to “controllable, traceable, and standardized.” Providers increasingly focus on the entire pre-analytical quality chain—patient identification, collection consistency, hemolysis/clotting control, sample logistics efficiency, and documentation of occupational exposure events. Therefore, touch-activated devices must not only be safe and easy to use, but also fit seamlessly into vacuum tube systems, phlebotomy carts, and specimen management workflows. Health-check centers and IVD-related service settings emphasize throughput and low error rates, favoring solutions that shorten cycle time and reduce rework. For populations with difficult venous access (pediatrics, geriatrics, oncology), the market leans toward variants with enhanced control and clear visual/functional feedback. Overall, product portfolios are evolving toward scenario-specific series and a complementary consumable ecosystem.
Key upstream inputs include medical-grade stainless-steel cannulae and bevel grinding, medical polymers for hubs/housings and activation structures, elastomers and seals for valves and leak prevention, transparent materials for observation windows, and connector components compatible with vacuum tubes or extension sets. For safety lockout and anti-rebound mechanisms, consistency of micro-springs, latches, and precision assembly determines activation feel and reliability. Because the device contacts blood directly or operates in near-blood environments, biocompatibility, sterilization compatibility, extractables/leachables control, and batch stability are critical. At scale, injection mold accuracy, automated assembly yield, and in-line inspection capabilities become decisive. Ultimately, upstream stability and quality management translate into first-stick performance, leakage risk, and safety-mechanism reliability—forming the foundation for brand trust and long-term institutional partnerships.
LP Information, Inc. (LPI) ' newest research report, the “Touch Activated Phlebotomy Device Industry Forecast” looks at past sales and reviews total world Touch Activated Phlebotomy Device sales in 2025, providing a comprehensive analysis by region and market sector of projected Touch Activated Phlebotomy Device sales for 2026 through 2032. With Touch Activated Phlebotomy Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Touch Activated Phlebotomy Device industry.
This Insight Report provides a comprehensive analysis of the global Touch Activated Phlebotomy Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Touch Activated Phlebotomy Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Touch Activated Phlebotomy Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Touch Activated Phlebotomy Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Touch Activated Phlebotomy Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Touch Activated Phlebotomy Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Peripheral Venous Phlebotomy
- Central Line Sampling Support
- Other
- Passive Safety
- Active Safet
- Passive/Auto-Engage
- User-Activated Mechanisms
- Other
- Hospitals
- Diagnostics/Reference Labs
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- BD
- Greiner Bio-One
- Terumo
- Nipro
- B. Braun
- Sarstedt
- Cardinal Health
- Medline
- ICU Medical
- What is the 10-year outlook for the global Touch Activated Phlebotomy Device market?
- What factors are driving Touch Activated Phlebotomy Device market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Touch Activated Phlebotomy Device market opportunities vary by end market size?
- How does Touch Activated Phlebotomy Device break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Touch Activated Phlebotomy Device Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Touch Activated Phlebotomy Device by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Touch Activated Phlebotomy Device by Country/Region, 2021, 2025 & 2032
2.2 Touch Activated Phlebotomy Device Segment by Type
2.2.1 Peripheral Venous Phlebotomy
2.2.2 Central Line Sampling Support
2.2.3 Other
2.2.4 Touch Activated Phlebotomy Device Sales by Type
2.2.4.1 Global Touch Activated Phlebotomy Device Sales Market Share by Type (2021-2026)
2.2.4.2 Global Touch Activated Phlebotomy Device Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Touch Activated Phlebotomy Device Sale Price by Type (2021-2026)
2.3 Touch Activated Phlebotomy Device Segment by Needlestick
2.3.1 Passive Safety
2.3.2 Active Safet
2.3.3 Touch Activated Phlebotomy Device Sales by Needlestick
2.3.3.1 Global Touch Activated Phlebotomy Device Sales Market Share by Needlestick (2021-2026)
2.3.3.2 Global Touch Activated Phlebotomy Device Revenue and Market Share by Needlestick (2021-2026)
2.3.3.3 Global Touch Activated Phlebotomy Device Sale Price by Needlestick (2021-2026)
2.4 Touch Activated Phlebotomy Device Segment by Safety Mechanism
2.4.1 Passive/Auto-Engage
2.4.2 User-Activated Mechanisms
2.4.3 Other
2.4.4 Touch Activated Phlebotomy Device Sales by Safety Mechanism
2.4.4.1 Global Touch Activated Phlebotomy Device Sales Market Share by Safety Mechanism (2021-2026)
2.4.4.2 Global Touch Activated Phlebotomy Device Revenue and Market Share by Safety Mechanism (2021-2026)
2.4.4.3 Global Touch Activated Phlebotomy Device Sale Price by Safety Mechanism (2021-2026)
2.5 Touch Activated Phlebotomy Device Segment by Application
2.5.1 Hospitals
2.5.2 Diagnostics/Reference Labs
2.5.3 Other
2.5.4 Touch Activated Phlebotomy Device Sales by Application
2.5.4.1 Global Touch Activated Phlebotomy Device Sale Market Share by Application (2021-2026)
2.5.4.2 Global Touch Activated Phlebotomy Device Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Touch Activated Phlebotomy Device Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Touch Activated Phlebotomy Device Breakdown Data by Company
3.1.1 Global Touch Activated Phlebotomy Device Annual Sales by Company (2021-2026)
3.1.2 Global Touch Activated Phlebotomy Device Sales Market Share by Company (2021-2026)
3.2 Global Touch Activated Phlebotomy Device Annual Revenue by Company (2021-2026)
3.2.1 Global Touch Activated Phlebotomy Device Revenue by Company (2021-2026)
3.2.2 Global Touch Activated Phlebotomy Device Revenue Market Share by Company (2021-2026)
3.3 Global Touch Activated Phlebotomy Device Sale Price by Company
3.4 Key Manufacturers Touch Activated Phlebotomy Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Touch Activated Phlebotomy Device Product Location Distribution
3.4.2 Players Touch Activated Phlebotomy Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TOUCH ACTIVATED PHLEBOTOMY DEVICE BY GEOGRAPHIC REGION
4.1 World Historic Touch Activated Phlebotomy Device Market Size by Geographic Region (2021-2026)
4.1.1 Global Touch Activated Phlebotomy Device Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Touch Activated Phlebotomy Device Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Touch Activated Phlebotomy Device Market Size by Country/Region (2021-2026)
4.2.1 Global Touch Activated Phlebotomy Device Annual Sales by Country/Region (2021-2026)
4.2.2 Global Touch Activated Phlebotomy Device Annual Revenue by Country/Region (2021-2026)
4.3 Americas Touch Activated Phlebotomy Device Sales Growth
4.4 APAC Touch Activated Phlebotomy Device Sales Growth
4.5 Europe Touch Activated Phlebotomy Device Sales Growth
4.6 Middle East & Africa Touch Activated Phlebotomy Device Sales Growth
5 AMERICAS
5.1 Americas Touch Activated Phlebotomy Device Sales by Country
5.1.1 Americas Touch Activated Phlebotomy Device Sales by Country (2021-2026)
5.1.2 Americas Touch Activated Phlebotomy Device Revenue by Country (2021-2026)
5.2 Americas Touch Activated Phlebotomy Device Sales by Type (2021-2026)
5.3 Americas Touch Activated Phlebotomy Device Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Touch Activated Phlebotomy Device Sales by Region
6.1.1 APAC Touch Activated Phlebotomy Device Sales by Region (2021-2026)
6.1.2 APAC Touch Activated Phlebotomy Device Revenue by Region (2021-2026)
6.2 APAC Touch Activated Phlebotomy Device Sales by Type (2021-2026)
6.3 APAC Touch Activated Phlebotomy Device Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Touch Activated Phlebotomy Device by Country
7.1.1 Europe Touch Activated Phlebotomy Device Sales by Country (2021-2026)
7.1.2 Europe Touch Activated Phlebotomy Device Revenue by Country (2021-2026)
7.2 Europe Touch Activated Phlebotomy Device Sales by Type (2021-2026)
7.3 Europe Touch Activated Phlebotomy Device Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Touch Activated Phlebotomy Device by Country
8.1.1 Middle East & Africa Touch Activated Phlebotomy Device Sales by Country (2021-2026)
8.1.2 Middle East & Africa Touch Activated Phlebotomy Device Revenue by Country (2021-2026)
8.2 Middle East & Africa Touch Activated Phlebotomy Device Sales by Type (2021-2026)
8.3 Middle East & Africa Touch Activated Phlebotomy Device Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Touch Activated Phlebotomy Device
10.3 Manufacturing Process Analysis of Touch Activated Phlebotomy Device
10.4 Industry Chain Structure of Touch Activated Phlebotomy Device
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Touch Activated Phlebotomy Device Distributors
11.3 Touch Activated Phlebotomy Device Customer
12 WORLD FORECAST REVIEW FOR TOUCH ACTIVATED PHLEBOTOMY DEVICE BY GEOGRAPHIC REGION
12.1 Global Touch Activated Phlebotomy Device Market Size Forecast by Region
12.1.1 Global Touch Activated Phlebotomy Device Forecast by Region (2027-2032)
12.1.2 Global Touch Activated Phlebotomy Device Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Touch Activated Phlebotomy Device Forecast by Type (2027-2032)
12.7 Global Touch Activated Phlebotomy Device Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 BD
13.1.1 BD Company Information
13.1.2 BD Touch Activated Phlebotomy Device Product Portfolios and Specifications
13.1.3 BD Touch Activated Phlebotomy Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 BD Main Business Overview
13.1.5 BD Latest Developments
13.2 Greiner Bio-One
13.2.1 Greiner Bio-One Company Information
13.2.2 Greiner Bio-One Touch Activated Phlebotomy Device Product Portfolios and Specifications
13.2.3 Greiner Bio-One Touch Activated Phlebotomy Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Greiner Bio-One Main Business Overview
13.2.5 Greiner Bio-One Latest Developments
13.3 Terumo
13.3.1 Terumo Company Information
13.3.2 Terumo Touch Activated Phlebotomy Device Product Portfolios and Specifications
13.3.3 Terumo Touch Activated Phlebotomy Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Terumo Main Business Overview
13.3.5 Terumo Latest Developments
13.4 Nipro
13.4.1 Nipro Company Information
13.4.2 Nipro Touch Activated Phlebotomy Device Product Portfolios and Specifications
13.4.3 Nipro Touch Activated Phlebotomy Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Nipro Main Business Overview
13.4.5 Nipro Latest Developments
13.5 B. Braun
13.5.1 B. Braun Company Information
13.5.2 B. Braun Touch Activated Phlebotomy Device Product Portfolios and Specifications
13.5.3 B. Braun Touch Activated Phlebotomy Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 B. Braun Main Business Overview
13.5.5 B. Braun Latest Developments
13.6 Sarstedt
13.6.1 Sarstedt Company Information
13.6.2 Sarstedt Touch Activated Phlebotomy Device Product Portfolios and Specifications
13.6.3 Sarstedt Touch Activated Phlebotomy Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Sarstedt Main Business Overview
13.6.5 Sarstedt Latest Developments
13.7 Cardinal Health
13.7.1 Cardinal Health Company Information
13.7.2 Cardinal Health Touch Activated Phlebotomy Device Product Portfolios and Specifications
13.7.3 Cardinal Health Touch Activated Phlebotomy Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Cardinal Health Main Business Overview
13.7.5 Cardinal Health Latest Developments
13.8 Medline
13.8.1 Medline Company Information
13.8.2 Medline Touch Activated Phlebotomy Device Product Portfolios and Specifications
13.8.3 Medline Touch Activated Phlebotomy Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Medline Main Business Overview
13.8.5 Medline Latest Developments
13.9 ICU Medical
13.9.1 ICU Medical Company Information
13.9.2 ICU Medical Touch Activated Phlebotomy Device Product Portfolios and Specifications
13.9.3 ICU Medical Touch Activated Phlebotomy Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 ICU Medical Main Business Overview
13.9.5 ICU Medical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Touch Activated Phlebotomy Device Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Touch Activated Phlebotomy Device by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Touch Activated Phlebotomy Device by Country/Region, 2021, 2025 & 2032
2.2 Touch Activated Phlebotomy Device Segment by Type
2.2.1 Peripheral Venous Phlebotomy
2.2.2 Central Line Sampling Support
2.2.3 Other
2.2.4 Touch Activated Phlebotomy Device Sales by Type
2.2.4.1 Global Touch Activated Phlebotomy Device Sales Market Share by Type (2021-2026)
2.2.4.2 Global Touch Activated Phlebotomy Device Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Touch Activated Phlebotomy Device Sale Price by Type (2021-2026)
2.3 Touch Activated Phlebotomy Device Segment by Needlestick
2.3.1 Passive Safety
2.3.2 Active Safet
2.3.3 Touch Activated Phlebotomy Device Sales by Needlestick
2.3.3.1 Global Touch Activated Phlebotomy Device Sales Market Share by Needlestick (2021-2026)
2.3.3.2 Global Touch Activated Phlebotomy Device Revenue and Market Share by Needlestick (2021-2026)
2.3.3.3 Global Touch Activated Phlebotomy Device Sale Price by Needlestick (2021-2026)
2.4 Touch Activated Phlebotomy Device Segment by Safety Mechanism
2.4.1 Passive/Auto-Engage
2.4.2 User-Activated Mechanisms
2.4.3 Other
2.4.4 Touch Activated Phlebotomy Device Sales by Safety Mechanism
2.4.4.1 Global Touch Activated Phlebotomy Device Sales Market Share by Safety Mechanism (2021-2026)
2.4.4.2 Global Touch Activated Phlebotomy Device Revenue and Market Share by Safety Mechanism (2021-2026)
2.4.4.3 Global Touch Activated Phlebotomy Device Sale Price by Safety Mechanism (2021-2026)
2.5 Touch Activated Phlebotomy Device Segment by Application
2.5.1 Hospitals
2.5.2 Diagnostics/Reference Labs
2.5.3 Other
2.5.4 Touch Activated Phlebotomy Device Sales by Application
2.5.4.1 Global Touch Activated Phlebotomy Device Sale Market Share by Application (2021-2026)
2.5.4.2 Global Touch Activated Phlebotomy Device Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Touch Activated Phlebotomy Device Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Touch Activated Phlebotomy Device Breakdown Data by Company
3.1.1 Global Touch Activated Phlebotomy Device Annual Sales by Company (2021-2026)
3.1.2 Global Touch Activated Phlebotomy Device Sales Market Share by Company (2021-2026)
3.2 Global Touch Activated Phlebotomy Device Annual Revenue by Company (2021-2026)
3.2.1 Global Touch Activated Phlebotomy Device Revenue by Company (2021-2026)
3.2.2 Global Touch Activated Phlebotomy Device Revenue Market Share by Company (2021-2026)
3.3 Global Touch Activated Phlebotomy Device Sale Price by Company
3.4 Key Manufacturers Touch Activated Phlebotomy Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Touch Activated Phlebotomy Device Product Location Distribution
3.4.2 Players Touch Activated Phlebotomy Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TOUCH ACTIVATED PHLEBOTOMY DEVICE BY GEOGRAPHIC REGION
4.1 World Historic Touch Activated Phlebotomy Device Market Size by Geographic Region (2021-2026)
4.1.1 Global Touch Activated Phlebotomy Device Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Touch Activated Phlebotomy Device Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Touch Activated Phlebotomy Device Market Size by Country/Region (2021-2026)
4.2.1 Global Touch Activated Phlebotomy Device Annual Sales by Country/Region (2021-2026)
4.2.2 Global Touch Activated Phlebotomy Device Annual Revenue by Country/Region (2021-2026)
4.3 Americas Touch Activated Phlebotomy Device Sales Growth
4.4 APAC Touch Activated Phlebotomy Device Sales Growth
4.5 Europe Touch Activated Phlebotomy Device Sales Growth
4.6 Middle East & Africa Touch Activated Phlebotomy Device Sales Growth
5 AMERICAS
5.1 Americas Touch Activated Phlebotomy Device Sales by Country
5.1.1 Americas Touch Activated Phlebotomy Device Sales by Country (2021-2026)
5.1.2 Americas Touch Activated Phlebotomy Device Revenue by Country (2021-2026)
5.2 Americas Touch Activated Phlebotomy Device Sales by Type (2021-2026)
5.3 Americas Touch Activated Phlebotomy Device Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Touch Activated Phlebotomy Device Sales by Region
6.1.1 APAC Touch Activated Phlebotomy Device Sales by Region (2021-2026)
6.1.2 APAC Touch Activated Phlebotomy Device Revenue by Region (2021-2026)
6.2 APAC Touch Activated Phlebotomy Device Sales by Type (2021-2026)
6.3 APAC Touch Activated Phlebotomy Device Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Touch Activated Phlebotomy Device by Country
7.1.1 Europe Touch Activated Phlebotomy Device Sales by Country (2021-2026)
7.1.2 Europe Touch Activated Phlebotomy Device Revenue by Country (2021-2026)
7.2 Europe Touch Activated Phlebotomy Device Sales by Type (2021-2026)
7.3 Europe Touch Activated Phlebotomy Device Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Touch Activated Phlebotomy Device by Country
8.1.1 Middle East & Africa Touch Activated Phlebotomy Device Sales by Country (2021-2026)
8.1.2 Middle East & Africa Touch Activated Phlebotomy Device Revenue by Country (2021-2026)
8.2 Middle East & Africa Touch Activated Phlebotomy Device Sales by Type (2021-2026)
8.3 Middle East & Africa Touch Activated Phlebotomy Device Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Touch Activated Phlebotomy Device
10.3 Manufacturing Process Analysis of Touch Activated Phlebotomy Device
10.4 Industry Chain Structure of Touch Activated Phlebotomy Device
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Touch Activated Phlebotomy Device Distributors
11.3 Touch Activated Phlebotomy Device Customer
12 WORLD FORECAST REVIEW FOR TOUCH ACTIVATED PHLEBOTOMY DEVICE BY GEOGRAPHIC REGION
12.1 Global Touch Activated Phlebotomy Device Market Size Forecast by Region
12.1.1 Global Touch Activated Phlebotomy Device Forecast by Region (2027-2032)
12.1.2 Global Touch Activated Phlebotomy Device Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Touch Activated Phlebotomy Device Forecast by Type (2027-2032)
12.7 Global Touch Activated Phlebotomy Device Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 BD
13.1.1 BD Company Information
13.1.2 BD Touch Activated Phlebotomy Device Product Portfolios and Specifications
13.1.3 BD Touch Activated Phlebotomy Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 BD Main Business Overview
13.1.5 BD Latest Developments
13.2 Greiner Bio-One
13.2.1 Greiner Bio-One Company Information
13.2.2 Greiner Bio-One Touch Activated Phlebotomy Device Product Portfolios and Specifications
13.2.3 Greiner Bio-One Touch Activated Phlebotomy Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Greiner Bio-One Main Business Overview
13.2.5 Greiner Bio-One Latest Developments
13.3 Terumo
13.3.1 Terumo Company Information
13.3.2 Terumo Touch Activated Phlebotomy Device Product Portfolios and Specifications
13.3.3 Terumo Touch Activated Phlebotomy Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Terumo Main Business Overview
13.3.5 Terumo Latest Developments
13.4 Nipro
13.4.1 Nipro Company Information
13.4.2 Nipro Touch Activated Phlebotomy Device Product Portfolios and Specifications
13.4.3 Nipro Touch Activated Phlebotomy Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Nipro Main Business Overview
13.4.5 Nipro Latest Developments
13.5 B. Braun
13.5.1 B. Braun Company Information
13.5.2 B. Braun Touch Activated Phlebotomy Device Product Portfolios and Specifications
13.5.3 B. Braun Touch Activated Phlebotomy Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 B. Braun Main Business Overview
13.5.5 B. Braun Latest Developments
13.6 Sarstedt
13.6.1 Sarstedt Company Information
13.6.2 Sarstedt Touch Activated Phlebotomy Device Product Portfolios and Specifications
13.6.3 Sarstedt Touch Activated Phlebotomy Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Sarstedt Main Business Overview
13.6.5 Sarstedt Latest Developments
13.7 Cardinal Health
13.7.1 Cardinal Health Company Information
13.7.2 Cardinal Health Touch Activated Phlebotomy Device Product Portfolios and Specifications
13.7.3 Cardinal Health Touch Activated Phlebotomy Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Cardinal Health Main Business Overview
13.7.5 Cardinal Health Latest Developments
13.8 Medline
13.8.1 Medline Company Information
13.8.2 Medline Touch Activated Phlebotomy Device Product Portfolios and Specifications
13.8.3 Medline Touch Activated Phlebotomy Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Medline Main Business Overview
13.8.5 Medline Latest Developments
13.9 ICU Medical
13.9.1 ICU Medical Company Information
13.9.2 ICU Medical Touch Activated Phlebotomy Device Product Portfolios and Specifications
13.9.3 ICU Medical Touch Activated Phlebotomy Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 ICU Medical Main Business Overview
13.9.5 ICU Medical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Touch Activated Phlebotomy Device Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Touch Activated Phlebotomy Device Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Peripheral Venous Phlebotomy
Table 4. Major Players of Central Line Sampling Support
Table 5. Major Players of Other
Table 6. Global Touch Activated Phlebotomy Device Sales by Type (2021-2026) & (K Units)
Table 7. Global Touch Activated Phlebotomy Device Sales Market Share by Type (2021-2026)
Table 8. Global Touch Activated Phlebotomy Device Revenue by Type (2021-2026) & ($ million)
Table 9. Global Touch Activated Phlebotomy Device Revenue Market Share by Type (2021-2026)
Table 10. Global Touch Activated Phlebotomy Device Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Major Players of Passive Safety
Table 12. Major Players of Active Safet
Table 13. Global Touch Activated Phlebotomy Device Sales by Needlestick (2021-2026) & (K Units)
Table 14. Global Touch Activated Phlebotomy Device Sales Market Share by Needlestick (2021-2026)
Table 15. Global Touch Activated Phlebotomy Device Revenue by Needlestick (2021-2026) & ($ million)
Table 16. Global Touch Activated Phlebotomy Device Revenue Market Share by Needlestick (2021-2026)
Table 17. Global Touch Activated Phlebotomy Device Sale Price by Needlestick (2021-2026) & (US$/Unit)
Table 18. Major Players of Passive/Auto-Engage
Table 19. Major Players of User-Activated Mechanisms
Table 20. Major Players of Other
Table 21. Global Touch Activated Phlebotomy Device Sales by Safety Mechanism (2021-2026) & (K Units)
Table 22. Global Touch Activated Phlebotomy Device Sales Market Share by Safety Mechanism (2021-2026)
Table 23. Global Touch Activated Phlebotomy Device Revenue by Safety Mechanism (2021-2026) & ($ million)
Table 24. Global Touch Activated Phlebotomy Device Revenue Market Share by Safety Mechanism (2021-2026)
Table 25. Global Touch Activated Phlebotomy Device Sale Price by Safety Mechanism (2021-2026) & (US$/Unit)
Table 26. Global Touch Activated Phlebotomy Device Sale by Application (2021-2026) & (K Units)
Table 27. Global Touch Activated Phlebotomy Device Sale Market Share by Application (2021-2026)
Table 28. Global Touch Activated Phlebotomy Device Revenue by Application (2021-2026) & ($ million)
Table 29. Global Touch Activated Phlebotomy Device Revenue Market Share by Application (2021-2026)
Table 30. Global Touch Activated Phlebotomy Device Sale Price by Application (2021-2026) & (US$/Unit)
Table 31. Global Touch Activated Phlebotomy Device Sales by Company (2021-2026) & (K Units)
Table 32. Global Touch Activated Phlebotomy Device Sales Market Share by Company (2021-2026)
Table 33. Global Touch Activated Phlebotomy Device Revenue by Company (2021-2026) & ($ millions)
Table 34. Global Touch Activated Phlebotomy Device Revenue Market Share by Company (2021-2026)
Table 35. Global Touch Activated Phlebotomy Device Sale Price by Company (2021-2026) & (US$/Unit)
Table 36. Key Manufacturers Touch Activated Phlebotomy Device Producing Area Distribution and Sales Area
Table 37. Players Touch Activated Phlebotomy Device Products Offered
Table 38. Touch Activated Phlebotomy Device Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global Touch Activated Phlebotomy Device Sales by Geographic Region (2021-2026) & (K Units)
Table 42. Global Touch Activated Phlebotomy Device Sales Market Share Geographic Region (2021-2026)
Table 43. Global Touch Activated Phlebotomy Device Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global Touch Activated Phlebotomy Device Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global Touch Activated Phlebotomy Device Sales by Country/Region (2021-2026) & (K Units)
Table 46. Global Touch Activated Phlebotomy Device Sales Market Share by Country/Region (2021-2026)
Table 47. Global Touch Activated Phlebotomy Device Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global Touch Activated Phlebotomy Device Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas Touch Activated Phlebotomy Device Sales by Country (2021-2026) & (K Units)
Table 50. Americas Touch Activated Phlebotomy Device Sales Market Share by Country (2021-2026)
Table 51. Americas Touch Activated Phlebotomy Device Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas Touch Activated Phlebotomy Device Sales by Type (2021-2026) & (K Units)
Table 53. Americas Touch Activated Phlebotomy Device Sales by Application (2021-2026) & (K Units)
Table 54. APAC Touch Activated Phlebotomy Device Sales by Region (2021-2026) & (K Units)
Table 55. APAC Touch Activated Phlebotomy Device Sales Market Share by Region (2021-2026)
Table 56. APAC Touch Activated Phlebotomy Device Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC Touch Activated Phlebotomy Device Sales by Type (2021-2026) & (K Units)
Table 58. APAC Touch Activated Phlebotomy Device Sales by Application (2021-2026) & (K Units)
Table 59. Europe Touch Activated Phlebotomy Device Sales by Country (2021-2026) & (K Units)
Table 60. Europe Touch Activated Phlebotomy Device Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe Touch Activated Phlebotomy Device Sales by Type (2021-2026) & (K Units)
Table 62. Europe Touch Activated Phlebotomy Device Sales by Application (2021-2026) & (K Units)
Table 63. Middle East & Africa Touch Activated Phlebotomy Device Sales by Country (2021-2026) & (K Units)
Table 64. Middle East & Africa Touch Activated Phlebotomy Device Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa Touch Activated Phlebotomy Device Sales by Type (2021-2026) & (K Units)
Table 66. Middle East & Africa Touch Activated Phlebotomy Device Sales by Application (2021-2026) & (K Units)
Table 67. Key Market Drivers & Growth Opportunities of Touch Activated Phlebotomy Device
Table 68. Key Market Challenges & Risks of Touch Activated Phlebotomy Device
Table 69. Key Industry Trends of Touch Activated Phlebotomy Device
Table 70. Touch Activated Phlebotomy Device Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Touch Activated Phlebotomy Device Distributors List
Table 73. Touch Activated Phlebotomy Device Customer List
Table 74. Global Touch Activated Phlebotomy Device Sales Forecast by Region (2027-2032) & (K Units)
Table 75. Global Touch Activated Phlebotomy Device Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas Touch Activated Phlebotomy Device Sales Forecast by Country (2027-2032) & (K Units)
Table 77. Americas Touch Activated Phlebotomy Device Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC Touch Activated Phlebotomy Device Sales Forecast by Region (2027-2032) & (K Units)
Table 79. APAC Touch Activated Phlebotomy Device Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe Touch Activated Phlebotomy Device Sales Forecast by Country (2027-2032) & (K Units)
Table 81. Europe Touch Activated Phlebotomy Device Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa Touch Activated Phlebotomy Device Sales Forecast by Country (2027-2032) & (K Units)
Table 83. Middle East & Africa Touch Activated Phlebotomy Device Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global Touch Activated Phlebotomy Device Sales Forecast by Type (2027-2032) & (K Units)
Table 85. Global Touch Activated Phlebotomy Device Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global Touch Activated Phlebotomy Device Sales Forecast by Application (2027-2032) & (K Units)
Table 87. Global Touch Activated Phlebotomy Device Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. BD Basic Information, Touch Activated Phlebotomy Device Manufacturing Base, Sales Area and Its Competitors
Table 89. BD Touch Activated Phlebotomy Device Product Portfolios and Specifications
Table 90. BD Touch Activated Phlebotomy Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. BD Main Business
Table 92. BD Latest Developments
Table 93. Greiner Bio-One Basic Information, Touch Activated Phlebotomy Device Manufacturing Base, Sales Area and Its Competitors
Table 94. Greiner Bio-One Touch Activated Phlebotomy Device Product Portfolios and Specifications
Table 95. Greiner Bio-One Touch Activated Phlebotomy Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Greiner Bio-One Main Business
Table 97. Greiner Bio-One Latest Developments
Table 98. Terumo Basic Information, Touch Activated Phlebotomy Device Manufacturing Base, Sales Area and Its Competitors
Table 99. Terumo Touch Activated Phlebotomy Device Product Portfolios and Specifications
Table 100. Terumo Touch Activated Phlebotomy Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Terumo Main Business
Table 102. Terumo Latest Developments
Table 103. Nipro Basic Information, Touch Activated Phlebotomy Device Manufacturing Base, Sales Area and Its Competitors
Table 104. Nipro Touch Activated Phlebotomy Device Product Portfolios and Specifications
Table 105. Nipro Touch Activated Phlebotomy Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Nipro Main Business
Table 107. Nipro Latest Developments
Table 108. B. Braun Basic Information, Touch Activated Phlebotomy Device Manufacturing Base, Sales Area and Its Competitors
Table 109. B. Braun Touch Activated Phlebotomy Device Product Portfolios and Specifications
Table 110. B. Braun Touch Activated Phlebotomy Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. B. Braun Main Business
Table 112. B. Braun Latest Developments
Table 113. Sarstedt Basic Information, Touch Activated Phlebotomy Device Manufacturing Base, Sales Area and Its Competitors
Table 114. Sarstedt Touch Activated Phlebotomy Device Product Portfolios and Specifications
Table 115. Sarstedt Touch Activated Phlebotomy Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Sarstedt Main Business
Table 117. Sarstedt Latest Developments
Table 118. Cardinal Health Basic Information, Touch Activated Phlebotomy Device Manufacturing Base, Sales Area and Its Competitors
Table 119. Cardinal Health Touch Activated Phlebotomy Device Product Portfolios and Specifications
Table 120. Cardinal Health Touch Activated Phlebotomy Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Cardinal Health Main Business
Table 122. Cardinal Health Latest Developments
Table 123. Medline Basic Information, Touch Activated Phlebotomy Device Manufacturing Base, Sales Area and Its Competitors
Table 124. Medline Touch Activated Phlebotomy Device Product Portfolios and Specifications
Table 125. Medline Touch Activated Phlebotomy Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Medline Main Business
Table 127. Medline Latest Developments
Table 128. ICU Medical Basic Information, Touch Activated Phlebotomy Device Manufacturing Base, Sales Area and Its Competitors
Table 129. ICU Medical Touch Activated Phlebotomy Device Product Portfolios and Specifications
Table 130. ICU Medical Touch Activated Phlebotomy Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. ICU Medical Main Business
Table 132. ICU Medical Latest Developments
Table 1. Touch Activated Phlebotomy Device Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Touch Activated Phlebotomy Device Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Peripheral Venous Phlebotomy
Table 4. Major Players of Central Line Sampling Support
Table 5. Major Players of Other
Table 6. Global Touch Activated Phlebotomy Device Sales by Type (2021-2026) & (K Units)
Table 7. Global Touch Activated Phlebotomy Device Sales Market Share by Type (2021-2026)
Table 8. Global Touch Activated Phlebotomy Device Revenue by Type (2021-2026) & ($ million)
Table 9. Global Touch Activated Phlebotomy Device Revenue Market Share by Type (2021-2026)
Table 10. Global Touch Activated Phlebotomy Device Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Major Players of Passive Safety
Table 12. Major Players of Active Safet
Table 13. Global Touch Activated Phlebotomy Device Sales by Needlestick (2021-2026) & (K Units)
Table 14. Global Touch Activated Phlebotomy Device Sales Market Share by Needlestick (2021-2026)
Table 15. Global Touch Activated Phlebotomy Device Revenue by Needlestick (2021-2026) & ($ million)
Table 16. Global Touch Activated Phlebotomy Device Revenue Market Share by Needlestick (2021-2026)
Table 17. Global Touch Activated Phlebotomy Device Sale Price by Needlestick (2021-2026) & (US$/Unit)
Table 18. Major Players of Passive/Auto-Engage
Table 19. Major Players of User-Activated Mechanisms
Table 20. Major Players of Other
Table 21. Global Touch Activated Phlebotomy Device Sales by Safety Mechanism (2021-2026) & (K Units)
Table 22. Global Touch Activated Phlebotomy Device Sales Market Share by Safety Mechanism (2021-2026)
Table 23. Global Touch Activated Phlebotomy Device Revenue by Safety Mechanism (2021-2026) & ($ million)
Table 24. Global Touch Activated Phlebotomy Device Revenue Market Share by Safety Mechanism (2021-2026)
Table 25. Global Touch Activated Phlebotomy Device Sale Price by Safety Mechanism (2021-2026) & (US$/Unit)
Table 26. Global Touch Activated Phlebotomy Device Sale by Application (2021-2026) & (K Units)
Table 27. Global Touch Activated Phlebotomy Device Sale Market Share by Application (2021-2026)
Table 28. Global Touch Activated Phlebotomy Device Revenue by Application (2021-2026) & ($ million)
Table 29. Global Touch Activated Phlebotomy Device Revenue Market Share by Application (2021-2026)
Table 30. Global Touch Activated Phlebotomy Device Sale Price by Application (2021-2026) & (US$/Unit)
Table 31. Global Touch Activated Phlebotomy Device Sales by Company (2021-2026) & (K Units)
Table 32. Global Touch Activated Phlebotomy Device Sales Market Share by Company (2021-2026)
Table 33. Global Touch Activated Phlebotomy Device Revenue by Company (2021-2026) & ($ millions)
Table 34. Global Touch Activated Phlebotomy Device Revenue Market Share by Company (2021-2026)
Table 35. Global Touch Activated Phlebotomy Device Sale Price by Company (2021-2026) & (US$/Unit)
Table 36. Key Manufacturers Touch Activated Phlebotomy Device Producing Area Distribution and Sales Area
Table 37. Players Touch Activated Phlebotomy Device Products Offered
Table 38. Touch Activated Phlebotomy Device Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global Touch Activated Phlebotomy Device Sales by Geographic Region (2021-2026) & (K Units)
Table 42. Global Touch Activated Phlebotomy Device Sales Market Share Geographic Region (2021-2026)
Table 43. Global Touch Activated Phlebotomy Device Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global Touch Activated Phlebotomy Device Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global Touch Activated Phlebotomy Device Sales by Country/Region (2021-2026) & (K Units)
Table 46. Global Touch Activated Phlebotomy Device Sales Market Share by Country/Region (2021-2026)
Table 47. Global Touch Activated Phlebotomy Device Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global Touch Activated Phlebotomy Device Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas Touch Activated Phlebotomy Device Sales by Country (2021-2026) & (K Units)
Table 50. Americas Touch Activated Phlebotomy Device Sales Market Share by Country (2021-2026)
Table 51. Americas Touch Activated Phlebotomy Device Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas Touch Activated Phlebotomy Device Sales by Type (2021-2026) & (K Units)
Table 53. Americas Touch Activated Phlebotomy Device Sales by Application (2021-2026) & (K Units)
Table 54. APAC Touch Activated Phlebotomy Device Sales by Region (2021-2026) & (K Units)
Table 55. APAC Touch Activated Phlebotomy Device Sales Market Share by Region (2021-2026)
Table 56. APAC Touch Activated Phlebotomy Device Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC Touch Activated Phlebotomy Device Sales by Type (2021-2026) & (K Units)
Table 58. APAC Touch Activated Phlebotomy Device Sales by Application (2021-2026) & (K Units)
Table 59. Europe Touch Activated Phlebotomy Device Sales by Country (2021-2026) & (K Units)
Table 60. Europe Touch Activated Phlebotomy Device Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe Touch Activated Phlebotomy Device Sales by Type (2021-2026) & (K Units)
Table 62. Europe Touch Activated Phlebotomy Device Sales by Application (2021-2026) & (K Units)
Table 63. Middle East & Africa Touch Activated Phlebotomy Device Sales by Country (2021-2026) & (K Units)
Table 64. Middle East & Africa Touch Activated Phlebotomy Device Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa Touch Activated Phlebotomy Device Sales by Type (2021-2026) & (K Units)
Table 66. Middle East & Africa Touch Activated Phlebotomy Device Sales by Application (2021-2026) & (K Units)
Table 67. Key Market Drivers & Growth Opportunities of Touch Activated Phlebotomy Device
Table 68. Key Market Challenges & Risks of Touch Activated Phlebotomy Device
Table 69. Key Industry Trends of Touch Activated Phlebotomy Device
Table 70. Touch Activated Phlebotomy Device Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Touch Activated Phlebotomy Device Distributors List
Table 73. Touch Activated Phlebotomy Device Customer List
Table 74. Global Touch Activated Phlebotomy Device Sales Forecast by Region (2027-2032) & (K Units)
Table 75. Global Touch Activated Phlebotomy Device Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas Touch Activated Phlebotomy Device Sales Forecast by Country (2027-2032) & (K Units)
Table 77. Americas Touch Activated Phlebotomy Device Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC Touch Activated Phlebotomy Device Sales Forecast by Region (2027-2032) & (K Units)
Table 79. APAC Touch Activated Phlebotomy Device Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe Touch Activated Phlebotomy Device Sales Forecast by Country (2027-2032) & (K Units)
Table 81. Europe Touch Activated Phlebotomy Device Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa Touch Activated Phlebotomy Device Sales Forecast by Country (2027-2032) & (K Units)
Table 83. Middle East & Africa Touch Activated Phlebotomy Device Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global Touch Activated Phlebotomy Device Sales Forecast by Type (2027-2032) & (K Units)
Table 85. Global Touch Activated Phlebotomy Device Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global Touch Activated Phlebotomy Device Sales Forecast by Application (2027-2032) & (K Units)
Table 87. Global Touch Activated Phlebotomy Device Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. BD Basic Information, Touch Activated Phlebotomy Device Manufacturing Base, Sales Area and Its Competitors
Table 89. BD Touch Activated Phlebotomy Device Product Portfolios and Specifications
Table 90. BD Touch Activated Phlebotomy Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. BD Main Business
Table 92. BD Latest Developments
Table 93. Greiner Bio-One Basic Information, Touch Activated Phlebotomy Device Manufacturing Base, Sales Area and Its Competitors
Table 94. Greiner Bio-One Touch Activated Phlebotomy Device Product Portfolios and Specifications
Table 95. Greiner Bio-One Touch Activated Phlebotomy Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Greiner Bio-One Main Business
Table 97. Greiner Bio-One Latest Developments
Table 98. Terumo Basic Information, Touch Activated Phlebotomy Device Manufacturing Base, Sales Area and Its Competitors
Table 99. Terumo Touch Activated Phlebotomy Device Product Portfolios and Specifications
Table 100. Terumo Touch Activated Phlebotomy Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Terumo Main Business
Table 102. Terumo Latest Developments
Table 103. Nipro Basic Information, Touch Activated Phlebotomy Device Manufacturing Base, Sales Area and Its Competitors
Table 104. Nipro Touch Activated Phlebotomy Device Product Portfolios and Specifications
Table 105. Nipro Touch Activated Phlebotomy Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Nipro Main Business
Table 107. Nipro Latest Developments
Table 108. B. Braun Basic Information, Touch Activated Phlebotomy Device Manufacturing Base, Sales Area and Its Competitors
Table 109. B. Braun Touch Activated Phlebotomy Device Product Portfolios and Specifications
Table 110. B. Braun Touch Activated Phlebotomy Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. B. Braun Main Business
Table 112. B. Braun Latest Developments
Table 113. Sarstedt Basic Information, Touch Activated Phlebotomy Device Manufacturing Base, Sales Area and Its Competitors
Table 114. Sarstedt Touch Activated Phlebotomy Device Product Portfolios and Specifications
Table 115. Sarstedt Touch Activated Phlebotomy Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Sarstedt Main Business
Table 117. Sarstedt Latest Developments
Table 118. Cardinal Health Basic Information, Touch Activated Phlebotomy Device Manufacturing Base, Sales Area and Its Competitors
Table 119. Cardinal Health Touch Activated Phlebotomy Device Product Portfolios and Specifications
Table 120. Cardinal Health Touch Activated Phlebotomy Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Cardinal Health Main Business
Table 122. Cardinal Health Latest Developments
Table 123. Medline Basic Information, Touch Activated Phlebotomy Device Manufacturing Base, Sales Area and Its Competitors
Table 124. Medline Touch Activated Phlebotomy Device Product Portfolios and Specifications
Table 125. Medline Touch Activated Phlebotomy Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Medline Main Business
Table 127. Medline Latest Developments
Table 128. ICU Medical Basic Information, Touch Activated Phlebotomy Device Manufacturing Base, Sales Area and Its Competitors
Table 129. ICU Medical Touch Activated Phlebotomy Device Product Portfolios and Specifications
Table 130. ICU Medical Touch Activated Phlebotomy Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. ICU Medical Main Business
Table 132. ICU Medical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Touch Activated Phlebotomy Device
Figure 2. Touch Activated Phlebotomy Device Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Touch Activated Phlebotomy Device Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Touch Activated Phlebotomy Device Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Touch Activated Phlebotomy Device Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Touch Activated Phlebotomy Device Sales Market Share by Country/Region (2025)
Figure 10. Touch Activated Phlebotomy Device Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Peripheral Venous Phlebotomy
Figure 12. Product Picture of Central Line Sampling Support
Figure 13. Product Picture of Other
Figure 14. Global Touch Activated Phlebotomy Device Sales Market Share by Type in 2026
Figure 15. Global Touch Activated Phlebotomy Device Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Passive Safety
Figure 17. Product Picture of Active Safet
Figure 18. Global Touch Activated Phlebotomy Device Sales Market Share by Needlestick in 2026
Figure 19. Global Touch Activated Phlebotomy Device Revenue Market Share by Needlestick (2021-2026)
Figure 20. Product Picture of Passive/Auto-Engage
Figure 21. Product Picture of User-Activated Mechanisms
Figure 22. Product Picture of Other
Figure 23. Global Touch Activated Phlebotomy Device Sales Market Share by Safety Mechanism in 2026
Figure 24. Global Touch Activated Phlebotomy Device Revenue Market Share by Safety Mechanism (2021-2026)
Figure 25. Touch Activated Phlebotomy Device Consumed in Hospitals
Figure 26. Global Touch Activated Phlebotomy Device Market: Hospitals (2021-2026) & (K Units)
Figure 27. Touch Activated Phlebotomy Device Consumed in Diagnostics/Reference Labs
Figure 28. Global Touch Activated Phlebotomy Device Market: Diagnostics/Reference Labs (2021-2026) & (K Units)
Figure 29. Touch Activated Phlebotomy Device Consumed in Other
Figure 30. Global Touch Activated Phlebotomy Device Market: Other (2021-2026) & (K Units)
Figure 31. Global Touch Activated Phlebotomy Device Sale Market Share by Application (2025)
Figure 32. Global Touch Activated Phlebotomy Device Revenue Market Share by Application in 2026
Figure 33. Touch Activated Phlebotomy Device Sales by Company in 2026 (K Units)
Figure 34. Global Touch Activated Phlebotomy Device Sales Market Share by Company in 2026
Figure 35. Touch Activated Phlebotomy Device Revenue by Company in 2026 ($ millions)
Figure 36. Global Touch Activated Phlebotomy Device Revenue Market Share by Company in 2026
Figure 37. Global Touch Activated Phlebotomy Device Sales Market Share by Geographic Region (2021-2026)
Figure 38. Global Touch Activated Phlebotomy Device Revenue Market Share by Geographic Region in 2026
Figure 39. Americas Touch Activated Phlebotomy Device Sales 2021-2026 (K Units)
Figure 40. Americas Touch Activated Phlebotomy Device Revenue 2021-2026 ($ millions)
Figure 41. APAC Touch Activated Phlebotomy Device Sales 2021-2026 (K Units)
Figure 42. APAC Touch Activated Phlebotomy Device Revenue 2021-2026 ($ millions)
Figure 43. Europe Touch Activated Phlebotomy Device Sales 2021-2026 (K Units)
Figure 44. Europe Touch Activated Phlebotomy Device Revenue 2021-2026 ($ millions)
Figure 45. Middle East & Africa Touch Activated Phlebotomy Device Sales 2021-2026 (K Units)
Figure 46. Middle East & Africa Touch Activated Phlebotomy Device Revenue 2021-2026 ($ millions)
Figure 47. Americas Touch Activated Phlebotomy Device Sales Market Share by Country in 2026
Figure 48. Americas Touch Activated Phlebotomy Device Revenue Market Share by Country (2021-2026)
Figure 49. Americas Touch Activated Phlebotomy Device Sales Market Share by Type (2021-2026)
Figure 50. Americas Touch Activated Phlebotomy Device Sales Market Share by Application (2021-2026)
Figure 51. United States Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 52. Canada Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 53. Mexico Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 54. Brazil Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 55. APAC Touch Activated Phlebotomy Device Sales Market Share by Region in 2026
Figure 56. APAC Touch Activated Phlebotomy Device Revenue Market Share by Region (2021-2026)
Figure 57. APAC Touch Activated Phlebotomy Device Sales Market Share by Type (2021-2026)
Figure 58. APAC Touch Activated Phlebotomy Device Sales Market Share by Application (2021-2026)
Figure 59. China Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 60. Japan Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 61. South Korea Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 62. Southeast Asia Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 63. India Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 64. Australia Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 65. China Taiwan Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 66. Europe Touch Activated Phlebotomy Device Sales Market Share by Country in 2026
Figure 67. Europe Touch Activated Phlebotomy Device Revenue Market Share by Country (2021-2026)
Figure 68. Europe Touch Activated Phlebotomy Device Sales Market Share by Type (2021-2026)
Figure 69. Europe Touch Activated Phlebotomy Device Sales Market Share by Application (2021-2026)
Figure 70. Germany Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 71. France Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 72. UK Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 73. Italy Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 74. Russia Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 75. Middle East & Africa Touch Activated Phlebotomy Device Sales Market Share by Country (2021-2026)
Figure 76. Middle East & Africa Touch Activated Phlebotomy Device Sales Market Share by Type (2021-2026)
Figure 77. Middle East & Africa Touch Activated Phlebotomy Device Sales Market Share by Application (2021-2026)
Figure 78. Egypt Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 79. South Africa Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 80. Israel Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 81. Turkey Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 82. GCC Countries Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of Touch Activated Phlebotomy Device in 2026
Figure 84. Manufacturing Process Analysis of Touch Activated Phlebotomy Device
Figure 85. Industry Chain Structure of Touch Activated Phlebotomy Device
Figure 86. Channels of Distribution
Figure 87. Global Touch Activated Phlebotomy Device Sales Market Forecast by Region (2027-2032)
Figure 88. Global Touch Activated Phlebotomy Device Revenue Market Share Forecast by Region (2027-2032)
Figure 89. Global Touch Activated Phlebotomy Device Sales Market Share Forecast by Type (2027-2032)
Figure 90. Global Touch Activated Phlebotomy Device Revenue Market Share Forecast by Type (2027-2032)
Figure 91. Global Touch Activated Phlebotomy Device Sales Market Share Forecast by Application (2027-2032)
Figure 92. Global Touch Activated Phlebotomy Device Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Touch Activated Phlebotomy Device
Figure 2. Touch Activated Phlebotomy Device Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Touch Activated Phlebotomy Device Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Touch Activated Phlebotomy Device Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Touch Activated Phlebotomy Device Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Touch Activated Phlebotomy Device Sales Market Share by Country/Region (2025)
Figure 10. Touch Activated Phlebotomy Device Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Peripheral Venous Phlebotomy
Figure 12. Product Picture of Central Line Sampling Support
Figure 13. Product Picture of Other
Figure 14. Global Touch Activated Phlebotomy Device Sales Market Share by Type in 2026
Figure 15. Global Touch Activated Phlebotomy Device Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Passive Safety
Figure 17. Product Picture of Active Safet
Figure 18. Global Touch Activated Phlebotomy Device Sales Market Share by Needlestick in 2026
Figure 19. Global Touch Activated Phlebotomy Device Revenue Market Share by Needlestick (2021-2026)
Figure 20. Product Picture of Passive/Auto-Engage
Figure 21. Product Picture of User-Activated Mechanisms
Figure 22. Product Picture of Other
Figure 23. Global Touch Activated Phlebotomy Device Sales Market Share by Safety Mechanism in 2026
Figure 24. Global Touch Activated Phlebotomy Device Revenue Market Share by Safety Mechanism (2021-2026)
Figure 25. Touch Activated Phlebotomy Device Consumed in Hospitals
Figure 26. Global Touch Activated Phlebotomy Device Market: Hospitals (2021-2026) & (K Units)
Figure 27. Touch Activated Phlebotomy Device Consumed in Diagnostics/Reference Labs
Figure 28. Global Touch Activated Phlebotomy Device Market: Diagnostics/Reference Labs (2021-2026) & (K Units)
Figure 29. Touch Activated Phlebotomy Device Consumed in Other
Figure 30. Global Touch Activated Phlebotomy Device Market: Other (2021-2026) & (K Units)
Figure 31. Global Touch Activated Phlebotomy Device Sale Market Share by Application (2025)
Figure 32. Global Touch Activated Phlebotomy Device Revenue Market Share by Application in 2026
Figure 33. Touch Activated Phlebotomy Device Sales by Company in 2026 (K Units)
Figure 34. Global Touch Activated Phlebotomy Device Sales Market Share by Company in 2026
Figure 35. Touch Activated Phlebotomy Device Revenue by Company in 2026 ($ millions)
Figure 36. Global Touch Activated Phlebotomy Device Revenue Market Share by Company in 2026
Figure 37. Global Touch Activated Phlebotomy Device Sales Market Share by Geographic Region (2021-2026)
Figure 38. Global Touch Activated Phlebotomy Device Revenue Market Share by Geographic Region in 2026
Figure 39. Americas Touch Activated Phlebotomy Device Sales 2021-2026 (K Units)
Figure 40. Americas Touch Activated Phlebotomy Device Revenue 2021-2026 ($ millions)
Figure 41. APAC Touch Activated Phlebotomy Device Sales 2021-2026 (K Units)
Figure 42. APAC Touch Activated Phlebotomy Device Revenue 2021-2026 ($ millions)
Figure 43. Europe Touch Activated Phlebotomy Device Sales 2021-2026 (K Units)
Figure 44. Europe Touch Activated Phlebotomy Device Revenue 2021-2026 ($ millions)
Figure 45. Middle East & Africa Touch Activated Phlebotomy Device Sales 2021-2026 (K Units)
Figure 46. Middle East & Africa Touch Activated Phlebotomy Device Revenue 2021-2026 ($ millions)
Figure 47. Americas Touch Activated Phlebotomy Device Sales Market Share by Country in 2026
Figure 48. Americas Touch Activated Phlebotomy Device Revenue Market Share by Country (2021-2026)
Figure 49. Americas Touch Activated Phlebotomy Device Sales Market Share by Type (2021-2026)
Figure 50. Americas Touch Activated Phlebotomy Device Sales Market Share by Application (2021-2026)
Figure 51. United States Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 52. Canada Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 53. Mexico Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 54. Brazil Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 55. APAC Touch Activated Phlebotomy Device Sales Market Share by Region in 2026
Figure 56. APAC Touch Activated Phlebotomy Device Revenue Market Share by Region (2021-2026)
Figure 57. APAC Touch Activated Phlebotomy Device Sales Market Share by Type (2021-2026)
Figure 58. APAC Touch Activated Phlebotomy Device Sales Market Share by Application (2021-2026)
Figure 59. China Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 60. Japan Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 61. South Korea Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 62. Southeast Asia Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 63. India Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 64. Australia Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 65. China Taiwan Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 66. Europe Touch Activated Phlebotomy Device Sales Market Share by Country in 2026
Figure 67. Europe Touch Activated Phlebotomy Device Revenue Market Share by Country (2021-2026)
Figure 68. Europe Touch Activated Phlebotomy Device Sales Market Share by Type (2021-2026)
Figure 69. Europe Touch Activated Phlebotomy Device Sales Market Share by Application (2021-2026)
Figure 70. Germany Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 71. France Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 72. UK Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 73. Italy Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 74. Russia Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 75. Middle East & Africa Touch Activated Phlebotomy Device Sales Market Share by Country (2021-2026)
Figure 76. Middle East & Africa Touch Activated Phlebotomy Device Sales Market Share by Type (2021-2026)
Figure 77. Middle East & Africa Touch Activated Phlebotomy Device Sales Market Share by Application (2021-2026)
Figure 78. Egypt Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 79. South Africa Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 80. Israel Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 81. Turkey Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 82. GCC Countries Touch Activated Phlebotomy Device Revenue Growth 2021-2026 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of Touch Activated Phlebotomy Device in 2026
Figure 84. Manufacturing Process Analysis of Touch Activated Phlebotomy Device
Figure 85. Industry Chain Structure of Touch Activated Phlebotomy Device
Figure 86. Channels of Distribution
Figure 87. Global Touch Activated Phlebotomy Device Sales Market Forecast by Region (2027-2032)
Figure 88. Global Touch Activated Phlebotomy Device Revenue Market Share Forecast by Region (2027-2032)
Figure 89. Global Touch Activated Phlebotomy Device Sales Market Share Forecast by Type (2027-2032)
Figure 90. Global Touch Activated Phlebotomy Device Revenue Market Share Forecast by Type (2027-2032)
Figure 91. Global Touch Activated Phlebotomy Device Sales Market Share Forecast by Application (2027-2032)
Figure 92. Global Touch Activated Phlebotomy Device Revenue Market Share Forecast by Application (2027-2032)
